t 593 has been researched along with epirizole in 1 studies
| Studies (t 593) | Trials (t 593) | Recent Studies (post-2010) (t 593) | Studies (epirizole) | Trials (epirizole) | Recent Studies (post-2010) (epirizole) |
|---|---|---|---|---|---|
| 14 | 0 | 1 | 93 | 4 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amagase, K; Kato, S; Okabe, S; Yamamoto, H | 1 |
1 other study(ies) available for t 593 and epirizole
| Article | Year |
|---|---|
Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Epirizole; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Pepsin A; Peptic Ulcer; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Psychological; Sulfones | 1996 |